SynthesisBMJ open2019

Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2-17 years: systematic review and meta-analysis.

Bruno Rodrigues Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.